Are clinical practice guidelines adequately considered in drug treatment of osteoarthritis patients? Results from the HERAS survey

Katrin Janhsen, Ulrich Thiem, Ender Engin & Ludger Pientka
Background and aim: Guidelines for osteoarthritis patients (OAP) focus on drug treatment of pain and inflammation. As there is a high risk for side-effects and interactions – especially in the vulnerable population of the elderly – evidence based recommendations for first choice drugs [for full text, please go to the a.m. URL]